DE69814848T2 - Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden - Google Patents

Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden Download PDF

Info

Publication number: DE69814848T2
Authority: DE; Germany
Prior art keywords: nucleotide sequence; intensity; probe; marker; pna
Prior art date: 1997-02-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69814848T

Other languages

German (de)

English (en)

Other versions

DE69814848D1 (de

Inventor

Xiao-Feng Eileen NIE

Min Yuan WU

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ingeneus Corp

Original Assignee

Ingeneus Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-27

Filing date

1998-02-23

Publication date

2004-05-06

1997-06-06 Priority claimed from US08/870,370 external-priority patent/US6060242A/en

1998-02-23 Application filed by Ingeneus Corp filed Critical Ingeneus Corp

2003-06-26 Publication of DE69814848D1 publication Critical patent/DE69814848D1/de

2004-05-06 Application granted granted Critical

2004-05-06 Publication of DE69814848T2 publication Critical patent/DE69814848T2/de

2018-02-24 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

239000000523 sample Substances 0.000 title claims abstract description 342
239000002773 nucleotide Substances 0.000 title claims abstract description 142
125000003729 nucleotide group Chemical group 0.000 claims abstract description 141
238000000034 method Methods 0.000 claims abstract description 112
238000009396 hybridization Methods 0.000 claims abstract description 50
239000007788 liquid Substances 0.000 claims abstract description 45
239000007787 solid Substances 0.000 claims abstract description 12
239000003550 marker Substances 0.000 claims description 47
108020004414 DNA Proteins 0.000 claims description 40
230000000295 complement effect Effects 0.000 claims description 40
238000001514 detection method Methods 0.000 claims description 27
102000053602 DNA Human genes 0.000 claims description 26
108091028043 Nucleic acid sequence Proteins 0.000 claims description 23
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 18
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 17
238000012360 testing method Methods 0.000 claims description 15
230000005855 radiation Effects 0.000 claims description 12
239000013642 negative control Substances 0.000 claims description 10
238000005119 centrifugation Methods 0.000 claims description 8
238000000926 separation method Methods 0.000 claims description 8
238000004925 denaturation Methods 0.000 claims description 5
230000036425 denaturation Effects 0.000 claims description 5
230000005684 electric field Effects 0.000 claims description 5
230000001678 irradiating effect Effects 0.000 claims description 5
239000013641 positive control Substances 0.000 claims description 5
238000001962 electrophoresis Methods 0.000 claims description 3
238000001914 filtration Methods 0.000 claims description 3
XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 2
229910052786 argon Inorganic materials 0.000 claims description 2
-1 argon ion Chemical class 0.000 claims description 2
230000015572 biosynthetic process Effects 0.000 claims description 2
238000010791 quenching Methods 0.000 claims description 2
230000000171 quenching effect Effects 0.000 claims description 2
238000012544 monitoring process Methods 0.000 claims 6
239000002244 precipitate Substances 0.000 claims 1
238000012163 sequencing technique Methods 0.000 abstract description 2
239000000243 solution Substances 0.000 description 67
238000005259 measurement Methods 0.000 description 42
239000012634 fragment Substances 0.000 description 31
238000002189 fluorescence spectrum Methods 0.000 description 26
239000000872 buffer Substances 0.000 description 22
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 13
239000008051 TBE buffer Substances 0.000 description 13
125000003275 alpha amino acid group Chemical group 0.000 description 11
150000007523 nucleic acids Chemical class 0.000 description 11
239000000203 mixture Substances 0.000 description 10
102000039446 nucleic acids Human genes 0.000 description 10
108020004707 nucleic acids Proteins 0.000 description 10
238000001228 spectrum Methods 0.000 description 10
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
230000035772 mutation Effects 0.000 description 9
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 8
108091093037 Peptide nucleic acid Proteins 0.000 description 8
239000000975 dye Substances 0.000 description 7
230000005284 excitation Effects 0.000 description 5
239000007850 fluorescent dye Substances 0.000 description 5
239000000126 substance Substances 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
108020004682 Single-Stranded DNA Proteins 0.000 description 4
239000000499 gel Substances 0.000 description 4
239000003446 ligand Substances 0.000 description 4
238000000746 purification Methods 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
0 CCC*(*CC)*(C)*(C)C(C(*)C(CCCCCC(C)CC(*(C)[N+]([O-])=O)O)N=O)O Chemical compound CCC*(*CC)*(C)*(C)C(C(*)C(CCCCCC(C)CC(*(C)[N+]([O-])=O)O)N=O)O 0.000 description 3
108020004635 Complementary DNA Proteins 0.000 description 3
239000003298 DNA probe Substances 0.000 description 3
102000023732 binding proteins Human genes 0.000 description 3
108091008324 binding proteins Proteins 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
230000000875 corresponding effect Effects 0.000 description 3
238000001917 fluorescence detection Methods 0.000 description 3
108090000623 proteins and genes Proteins 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
238000003556 assay Methods 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
238000002372 labelling Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
239000002184 metal Substances 0.000 description 2
230000003287 optical effect Effects 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
230000008685 targeting Effects 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
238000012546 transfer Methods 0.000 description 2
SKBXVAOMEVOTGJ-UHFFFAOYSA-N xi-Pinol Chemical compound CC1=CCC2C(C)(C)OC1C2 SKBXVAOMEVOTGJ-UHFFFAOYSA-N 0.000 description 2
125000002861 (C1-C4) alkanoyl group Chemical group 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
PTDZLXBJOJLWKG-UHFFFAOYSA-N 5-(bromomethyl)-1h-pyrimidine-2,4-dione Chemical compound BrCC1=CNC(=O)NC1=O PTDZLXBJOJLWKG-UHFFFAOYSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
102000001218 Rec A Recombinases Human genes 0.000 description 1
108010055016 Rec A Recombinases Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
101150104425 T4 gene Proteins 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000000137 annealing Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000011324 bead Substances 0.000 description 1
239000012148 binding buffer Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
238000005251 capillar electrophoresis Methods 0.000 description 1
238000001444 catalytic combustion detection Methods 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000001934 delay Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000010291 electrical method Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
238000000198 fluorescence anisotropy Methods 0.000 description 1
239000012520 frozen sample Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
210000003917 human chromosome Anatomy 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
230000002687 intercalation Effects 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
238000002955 isolation Methods 0.000 description 1
XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
108700025694 p53 Genes Proteins 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
238000012797 qualification Methods 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
238000012552 review Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
229950005143 sitosterol Drugs 0.000 description 1
241000894007 species Species 0.000 description 1
ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 1
229950000329 thiouracil Drugs 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
229940035893 uracil Drugs 0.000 description 1
238000012795 verification Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1
238000005406 washing Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000012224 working solution Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DE69814848T 1997-02-27 1998-02-23 Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden Expired - Fee Related DE69814848T2 (de)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US80790197A	1997-02-27	1997-02-27
US807901		1997-02-27
US870370		1997-06-06
US08/870,370 US6060242A (en)	1997-02-27	1997-06-06	PNA diagnostic methods
PCT/IB1998/000521 WO1998038334A1 (en)	1997-02-27	1998-02-23	Assaying nucleotides in solution using pna probes

Publications (2)

Publication Number	Publication Date
DE69814848D1 DE69814848D1 (de)	2003-06-26
DE69814848T2 true DE69814848T2 (de)	2004-05-06

Family

ID=27123055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69814848T Expired - Fee Related DE69814848T2 (de)	1997-02-27	1998-02-23	Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden

Country Status (13)

Country	Link
EP (1)	EP0975800B1 (2)
JP (1)	JP4110223B2 (2)
AT (1)	ATE241018T1 (2)
AU (1)	AU736701B2 (2)
CA (1)	CA2282704C (2)
CY (1)	CY2406B1 (2)
DE (1)	DE69814848T2 (2)
DK (1)	DK0975800T3 (2)
ES (1)	ES2202821T3 (2)
IN (1)	IN188176B (2)
PT (1)	PT975800E (2)
TW (1)	TW389791B (2)
WO (1)	WO1998038334A1 (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4034351B2 (ja)	1996-04-25	2008-01-16	バイオアレイソリューションズエルエルシー	粒子近接表面の光制御した動電学的アッセンブリ
US6251591B1 (en) *	1997-02-27	2001-06-26	Lorne Park Research, Inc.	Quantitative method for detecting nucleotide concentration
US6046004A (en) *	1997-02-27	2000-04-04	Lorne Park Research, Inc.	Solution hybridization of nucleic acids with antisense probes having modified backbones
WO2000034521A1 (en) *	1998-12-08	2000-06-15	Boston Probes, Inc.	Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
DE69938400T2 (de) *	1998-12-08	2009-04-23	Boston Probes, Inc., Bedford	Verfahren, Kits und Zusammensetzungen zur Identifizierung von elektrostatisch an Matrizen gebundenen Nukleinsäuren
US6656692B2 (en) *	1999-12-21	2003-12-02	Ingeneus Corporation	Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
US6537755B1 (en) *	1999-03-25	2003-03-25	Radoje T. Drmanac	Solution-based methods and materials for sequence analysis by hybridization
US6265170B1 (en) *	2000-01-24	2001-07-24	Ingeneus Corporation	Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
US7220541B2 (en) *	2000-01-24	2007-05-22	Ingeneus, Inc.	Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
US9709559B2 (en)	2000-06-21	2017-07-18	Bioarray Solutions, Ltd.	Multianalyte molecular analysis using application-specific random particle arrays
EP1392853B1 (en)	2000-08-30	2006-04-26	Avi Biopharma, Inc.	Method for analysis of oligonucleotide analogs
US7262063B2 (en)	2001-06-21	2007-08-28	Bio Array Solutions, Ltd.	Directed assembly of functional heterostructures
EP1463825B1 (en)	2001-10-15	2017-12-06	BioArray Solutions Ltd.	Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US7810380B2 (en)	2003-03-25	2010-10-12	Tearlab Research, Inc.	Systems and methods for collecting tear film and measuring tear film osmolarity
US7041453B2 (en)	2002-08-22	2006-05-09	Bioarray Solutions Ltd.	Molecular constructs and methods of use for detection of biochemical reactions
US7526114B2 (en)	2002-11-15	2009-04-28	Bioarray Solutions Ltd.	Analysis, secure access to, and transmission of array images
CA2539824C (en)	2003-09-22	2015-02-03	Xinwen Wang	Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
EP1678495A4 (en) *	2003-10-20	2007-06-27	Univ California	TRANSDUCTION SYSTEMS IN THE NANOMASSIC STATION FOR DETECTING MOLECULAR INTERACTIONS
CA2899287A1 (en)	2003-10-28	2005-05-12	Bioarray Solutions Ltd.	Optimization of gene expression analysis using immobilized capture probes
US7848889B2 (en)	2004-08-02	2010-12-07	Bioarray Solutions, Ltd.	Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
ES2546743B1 (es)	2014-03-28	2016-07-07	Institut D'investigació Biomèdica De Bellvitge (Idibell)	Marcadores mitocondriales de enfermedades neurodegenerativas
CN106716116B (zh)	2014-09-23	2021-04-27	蒂尔实验室研究有限公司	用于微流体泪液收集和感兴趣的分析物的横向流动分析的集成的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0232967B1 (en) *	1986-01-10	1993-04-28	Amoco Corporation	Competitive homogeneous assay
EP0533906A4 (en) *	1991-04-11	1994-09-28	Baxter Diagnostics Inc	Detection of dna/rna by fluorescence polarization
US5539082A (en) *	1993-04-26	1996-07-23	Nielsen; Peter E.	Peptide nucleic acids
DE4216949C2 (de) *	1992-05-22	1997-07-24	Christoph Prof Dr Dr Cremer	Nichtenzymatisches Verfahren zur In-situ-Hybridisierung bei spezifischen Proben
JPH11512617A (ja) *	1995-10-06	1999-11-02	パーセプテイブ・バイオシステムズ・インコーポレイテツド	ペプチド核酸プローブを用いるハイブリダイゼーション分析のための方法、装置及びキット

1998
- 1998-02-23 JP JP53746398A patent/JP4110223B2/ja not_active Expired - Fee Related
- 1998-02-23 PT PT98910911T patent/PT975800E/pt unknown
- 1998-02-23 ES ES98910911T patent/ES2202821T3/es not_active Expired - Lifetime
- 1998-02-23 EP EP98910911A patent/EP0975800B1/en not_active Expired - Lifetime
- 1998-02-23 CA CA002282704A patent/CA2282704C/en not_active Expired - Fee Related
- 1998-02-23 WO PCT/IB1998/000521 patent/WO1998038334A1/en not_active Ceased
- 1998-02-23 DE DE69814848T patent/DE69814848T2/de not_active Expired - Fee Related
- 1998-02-23 AT AT98910911T patent/ATE241018T1/de not_active IP Right Cessation
- 1998-02-23 DK DK98910911T patent/DK0975800T3/da active
- 1998-02-23 AU AU65135/98A patent/AU736701B2/en not_active Ceased
- 1998-02-26 IN IN486DE1998 patent/IN188176B/en unknown
- 1998-03-12 TW TW087102841A patent/TW389791B/zh not_active IP Right Cessation
2004
- 2004-02-13 CY CY0400009A patent/CY2406B1/xx unknown

Also Published As

Publication number	Publication date
DE69814848D1 (de)	2003-06-26
PT975800E (pt)	2003-10-31
AU6513598A (en)	1998-09-18
TW389791B (en)	2000-05-11
CA2282704A1 (en)	1998-09-03
CY2406B1 (en)	2004-09-10
ATE241018T1 (de)	2003-06-15
CA2282704C (en)	2007-11-13
AU736701B2 (en)	2001-08-02
ES2202821T3 (es)	2004-04-01
JP4110223B2 (ja)	2008-07-02
EP0975800A1 (en)	2000-02-02
IN188176B (2)	2002-08-31
WO1998038334A1 (en)	1998-09-03
DK0975800T3 (da)	2003-09-22
JP2001514497A (ja)	2001-09-11
EP0975800B1 (en)	2003-05-21

Legal Events

Date	Code	Title	Description
2004-06-17	8364	No opposition during term of opposition
2009-12-17	8339	Ceased/non-payment of the annual fee

Publication	Publication Date	Title
DE69814848T2 (de)	2004-05-06	Untersuchung von nukleotiden in loesung mit hilfe von pna-sonden
DE69637065T2 (de)	2008-01-03	Die bestimmung von nukleinsäuren und nukleinsäure-einheiten
US6060242A (en)	2000-05-09	PNA diagnostic methods
Ferguson-Smith	1997	Genetic analysis by chromosome sorting and painting: phylogenetic and diagnostic applications
DE60036307T2 (de)	2008-05-29	Fluoreszenzintensitätstest für duplex- und triplex-nukleinsäurehybridisierung in lösung unter verwendung von fluoreszenzinterkalatoren
DE69506393T2 (de)	1999-07-01	Hybridisation-ligitation-verfahren zum nachweis von spezifischen dns sequenzen
CA2295333C (en)	2005-03-01	Assaying nucleotides in solution using a fluorescent intensity quenching effect
EP0925373B1 (de)	2003-10-22	Verfahren zum nachweis von nukleinsäuren unter ermittlung der masse
US6046004A (en)	2000-04-04	Solution hybridization of nucleic acids with antisense probes having modified backbones
DE3854743T2 (de)	1996-05-09	Verfahren zur schnellen basensequenzierung in dns und rns.
DE69736637T2 (de)	2007-11-15	Multiplex amplifikation kurzer tandem repeat loci
DE68909514T2 (de)	1994-01-20	Verfahren zur gleichzeitigen Bestimmung von DNS-Sequenzvariationen von zahlreichen Stellen und ein Satz dafür.
DE68926238T2 (de)	1996-10-02	Dns-analyse verfahren mit genamplifikation und magnetischen teilchen
DE19935772C2 (de)	2002-11-07	Verfahren zur relativen Quantifizierung der Methylierung von Cytosin Basen in DNA-Proben
DE69003477T2 (de)	1994-01-27	Verfahren zum Nachweis von Nucleinsäuren.
DE69936379T2 (de)	2008-02-28	Verfahren zur genotypisierung und dna-analyse
EP1415003A2 (de)	2004-05-06	Vorrichtung zur analyse von nukleinsäure
US6251591B1 (en)	2001-06-26	Quantitative method for detecting nucleotide concentration
DE69605803T2 (de)	2000-07-20	Nachweis von fehlpaarungen durch spaltung mit resolvase auf einem festträger
WO1999047701A1 (de)	1999-09-23	Verfahren zum nachweis einer nukleotidsequenz
EP2126134A1 (de)	2009-12-02	Verfahren und testkit zum schnellen nachweis spezifischer nukleinsäuresequenzen, insbesondere zum nachweis von mutationen oder snp's
DE69724375T2 (de)	2004-06-24	Verfahren zur Messung der Polynukleotidkonzentration
DE19806962B4 (de)	2004-08-05	Markierung von Nukleinsäuren mit speziellen Probengemischen
EP1307589A2 (de)	2003-05-07	Verfahren zum nachweis von mutationen in nucleotidsequenzen
DE60201441T2 (de)	2005-10-27	Verfahren zur analyse der dna-methylierung unter verwendung von fluoreszenzpolarisation